Content uploaded by Bulent Enis Sekerel
Author content
All content in this area was uploaded by Bulent Enis Sekerel on May 23, 2019
Content may be subject to copyright.
A 50-year-old man began experiencing
nausea, breathing difficulty, and hives on
his back and buttocks 10 min after eating
Quorn.
Those anecdotal reports are supported
by other data. Marlow Foods Ltd.,
Quorn’s producer, receives about 100
adverse-reaction reports (including sev-
eral IgE food-allergy reactions) annually
(1). An ‘idiosyncratic responseof vom-
iting and diarrhoea occurred in 10 com-
plainants (2). Two complainants had a
skin-prick test response to mycoprotein
>2 mm. Food challenges were not
conducted.
In a company-sponsored, double-blind
study, 200 volunteers ate up to 15 g (dry
weight) of mycoprotein up to eight times
over 4 weeks (3). Another 100 volunteers
ate foods without mycoprotein. Six peo-
ple in the test group vomited a total of
seven times. Three of those people agreed
to rechallenges (up to four), with one
person vomiting again (4). One person in
the control group vomited, but was not
rechallenged. In contrast, another com-
pany-sponsored study did not detect
symptoms that the researchers ascribed
to the test material (5).
Research is needed to find the mech-
anism(s) by which mycoprotein causes
symptoms. Regardless of the mechanism,
physicians should be aware that Quorn
may cause illnesses. Acceptance by gov-
ernment agencies (6) of Quorn as being
safe raises questions about the adequacy
of those agenciespremarket reviews and
postmarket monitoring of novel ingredi-
ents.
Center for Science in the Public Interest 1875
Connecticut Ave. NW Suite 300 Washington,
DC, USA
Tel: 202-777-8328
Fax: 202-265-4954
E-mail: mjacobson@cspinet.org
Accepted for publication 2 January 2003
Allergy 2003: 58:455–456
Copyright Blackwell Munksgaard 2003
ISSN 0105-4538
References
1. Food and Drug Administration, FDA.
GRAS Notification for Mycoprotein,
Marlow Foods Ltd., 30 Nov 2001. (On file
at the US FDA).
2. Tee RD, Gordon DJ, Welch JA, Newman
Taylor AJ. Investigation of possible
adverse allergic reactions to mycoprotein
(‘Quorn). Clin Exper Allergy 1992;23:
257–260.
3. R.H.M. Research Limited.Large scale
volunteer trial on mycoprotein (A3/5).
R. H. M. Research Limited, High
Wycombe, Buckinghamshire: 1977.
(On file at the FDA.)
4. R.H.M. Research Limited.Supplementary
studies on subjects who consumed A3/5 my-
coprotein in a large scale volunteer trial
conducted November/December 1977.R.H.
M. Research Limited, High Wycombe,
Buckinghamshire: 1978. (On file at the
FDA.)
5. Udall JN, Lo,CW,Young VR,
Scrimshaw NS. The tolerance and nutri-
tional value of two microfungal foods in
human subjects. Am J Clin Nutr
1984;40:285–292.
6. Agency Response Letter, GRAS Notice
No. GRN 000091, Office of Food Additive
Safety, Center for Food Safety and Applied
Nutrition, US Food and Drug Adminis-
tration, 7 Jan 2002. (http://www.cfsan.
fda.gov/rdb/opa-g091.html; accessed
23 Dec. 2002).
A case of isolated rice allergy
F. Orhan, B. E. Sekerel*
Key words: food allergy; gastrointestinal symptoms;
rice; urticaria.
Rice (Oryza sativa) belongs to the sub-
family of Oryzoidea which is a member of
the Graminea
family. Although
rice is one of the
most common
cereals produced
and consumed
around the
world, there have been only a few reports
on rice allergy most of which define
contact urticaria caused by raw rice (1, 2).
There are only two reports in the litera-
ture describing immediate hypersensitiv-
ity reactions after ingestion of rice (3, 4).
A 9-year-old girl was admitted to our
asthma clinic for routine follow-up visit
and had been under regular follow-up
during the last 2 years. She had been found
allergic to grass pollens through intrader-
mal but not epidermal tests. However, her
history was not suggestive of any seasonal
symptoms. Her skin prick tests (SPTs)
with other common inhalant (ALK,
Horsholm, Denmark) (mites, weeds, trees,
animal dander, and molds) and food
allergen extracts (Allergopharma,
Reinbek, Germany) (hen’s egg, milk, soy,
wheat, fish, and peanut), and her specific
IgE to grass pollens had also been found
negative. During that visit, her parents
informed that she ‘dislikesfoods consti-
tuting rice and avoided eating them for the
last 3 years. A couple of attempts to feed
her with rice resulted in immediate nausea,
abdominal pain and diarrhea. On one
occasion, she had suffered urticaria–angi-
oedema in the kitchen when her mother
was sorting rice.
We performed SPT (Allergopharma,
Reinbek, Germany) and prick–prick tests
with various cereals including rice, wheat,
barley, oat and lentil, and demonstrated a
(++++) wheal and flare reaction only
to rice with both tests. The total IgE
concentration was 165 kU/l, and IgE
specific to rice (CAP-FEIA, Pharmacia,
Uppsala, Sweden) was 13.2 kU/l
(Class 3). For a more definitive diagnosis
we performed a double-blind, placebo-
controlled food challenge which result in
nausea, abdominal pain and diarrhea
after 10 min of ingestion.
Although our patient demonstrated
positive response to grass pollens through
intradermal skin tests, her SPT response
and specific IgE to grass pollens were
negative, and her asthma symptoms were
perennial rather than seasonal. It has
been pointed out that the presence of a
positive intradermal skin test response in
the presence of a negative SPT response
does not indicate the presence of a
clinically significant sensitivity (5). Thus,
we excluded grass pollen sensitivity.
Cereal grains may show cross-reactivity
with grass pollens and each other. Our
patient had no problems when eating
other cereals. Her SPTs and prick–prick
tests with available cereals were also
negative. Therefore, it seems rice allergy
in our patient is isolated instead of being
a co-sensitization to grass pollens or
other cereals.
Rice allergy may lead
to urticarial lesions via
inhalation.
456
ALLERGY Net
Our patient exhibits the symptoms of
two different systems by two different
routes of exposure of two different forms
of rice. The first is ingestion of cooked
rice resulted in acute gastrointestinal
symptoms. The second is urticaria–angi-
oedema while her mother was sorting
rice, possibly caused by inhalation of
minute particles of raw rice. Inhalation of
foodstuffs in aerosol forms may cause
allergic food reactions. Also, inhalant
allergens may solely provoke urticaria
without associated allergic rhinitis or
asthma (6). To our knowledge, however,
IgE-mediated allergic symptoms limited
to skin following inhalation of food
allergens have not been reported to date.
Hacettepe University Faculty of Medicine
Department of Pediatric Allergy & Asthma
Sihhiye 06100 Ankara, Turkey
Tel: +90 312 3051700
Fax: +90 312 3112357
E-mail: b_sekerel@yahoo.com
Accepted for publication 22 January 2003
Allergy 2003: 58:456–457
Copyright Blackwell Munksgaard 2003
ISSN 0105-4538
References
1. Yamakawa Y, Ohsuna H, Aihara M,
Tsubaki K, Ikezawa Z. Contact urticaria
from rice. Contact Dermatitis 2001;44:
91–93.
2. Lezaun A, Igea JM, Quirce S, Cuecas M,
Parra F, Alonso MD, Martin JA,
Cano MS. Asthma and contact urticaria
caused by rice in a housewife. Allergy
1994;49:92–95.
3. Wu
¨thrich B, Scheitlin T, Ballmer-
Weber B. Isolated allergy to rice. Allergy
2002;57:263–64.
4. Arai T, Takaya T, Ito Y, Hayakawa K,
Toshima S, Shibuya C, Nomura M,
Yoshimi N, Shibayama M, Yasuda Y.
Bronchial asthma induced by rice. Intern
Med 1998;37:98–101.
5. Nelson HS, Oppenheimer J, Buchmeier A,
Kordash TR, Freshwater LL. An
assessment of the role of intradermal skin
testing in the diagnosis of clinically relevant
allergy to timothy grass. J Allergy Clin
Immunol 1996;97:1193–1201.
6. Lee IW, Ahn SK, Choi EH, Lee SH.
Urticarial reaction following the inhala-
tion of nicotine in tobacco smoke.
Br J Dermatol 1998;138:486–488.
Type I sensitization towards
patent blue as a cause of
anaphylaxis
K. Forschner, A. Kleine-Tebbe, T. Zuberbier, M. Worm*
Key words: anaphylaxis; patent blue; lymphography.
Detection and excision of sentinel lymph
nodes is an established technique for
early staging and
treatment of not
only malignant
melanoma, but
also of other
cancers (1, 2).
Allergic reactions to patent blue were
firstly reported in the 1960s and 1970s
(3, 4). Recently a few cases of anaphy-
laxis to patent blue after lymph node
mapping were published (5–7). We report
a 37-year-old female patient with a
superficial spreading malignant
melanoma who underwent lymph
node mapping. The patient was sedated
with midazolam (Dormicum
) and
received anaesthesia with articain
(Xylonest
1%).
Five minutes after intralymphatic
injection of 1 ml patent blue (Guerbet
)
the patient developed a generalized
urticaria and angiooedema. A few
minutes later, the patient became
hypotensive (50/40 mmHg) and lost
consciousness. The anaphylactic reaction
was treated immediately with adrenaline
(0.2 mg), prednisone (500 mg) and
dimetindenmaleat (8 mg) intravenously
and the patient recovered completely
within 30 min. The patient’s history
revealed neither other allergic diseases
like atopic dermatitis, allergic rhinitis or
allergic asthma nor previous anaphylaxis.
Accordingly, the total serum IgE anti-
bodies were normal (19.7 kU/l), specific
IgE to latex was negative (>0.35 kU/l)
and no specific serum IgE was found
regarding the most frequent inhalant
allergens (SX1). Also the tryptase level
was normal (4.79 lg/l).
Three weeks postoperatively a skin
prick test (SPT) was performed. All used
drugs were tested. The SPT using articain
(1%), diazepam and midazolam was
negative. By contrast, a strong positive
SPT towards patent blue 1 : 100 was
found (Fig. 1). In five control individuals
SPT with patent blue (dilution 1 : 100)
was negative. These findings indicate a
type I allergy towards patent blue in this
patient as a cause of the perioperative
anaphylaxis.
Patent blue is a widely used agent in
textile, paper, agriculture industries,
cosmetic and medical products. In the
past, a frequency of type I sensitization
towards patent blue of 2.7% has been
reported (8). A recent review revealed
adverse reactions to injection of isosulfan
blue dye during sentinel lymph node
mapping in breast cancer patients in
1.6% of documented allergic reactions
(n¼2392) (1). Most reactions produced
urticaria and pruritus (69%) but only
0.5% of the patients showed hypotensive
reactions. As the procedure of sentinel
lymphnode biopsy becomes more fre-
quent the risk of an increased incidence
of adverse reactions to patent blue may
be expected. The value of preoperative
performed SPT to rule out preexisting
type I sensitization towards patent blue
will need to be clarified by prospective
controlled studies.
*Department of Dermatology and Allergy
Charite
´, Humboldt University
Schumannstrasse 20/21
D-10117 Berlin Germany
Tel: 04930450518105
Fax: 04930450518958
E-mail: margitta.worm@charite.de
Accepted for publication 17 January 2003
Allergy 2003: 58:457–458
Copyright Blackwell Munksgaard 2003
ISSN 0105-4538
Figure 1. Positive skin prick test with patent blue
at 1 : 100 dilution.
Patent blue is
frequently used for
lymphnode mapping.
457
ALLERGY Net